Press releases
- Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
- Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
- Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
More ▼
Key statistics
On Tuesday, Kezar Life Sciences Inc (2KZ:FRA) closed at 0.452, 5.12% above its 52-week low of 0.43, set on May 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.452 |
---|---|
High | 0.452 |
Low | 0.452 |
Bid | 0.62 |
Offer | 0.66 |
Previous close | 0.446 |
Average volume | 365.00 |
---|---|
Shares outstanding | 72.80m |
Free float | 62.00m |
P/E (TTM) | -- |
Market cap | 50.52m USD |
EPS (TTM) | -1.40 USD |
Data delayed at least 15 minutes, as of Jun 04 2024 07:01 BST.
More ▼